Return On Equity in % of CRISPR Therapeutics AG from Q2 2017 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
CRISPR Therapeutics AG quarterly/annual Return On Equity history and growth rate from Q2 2017 to Q3 2025.
  • CRISPR Therapeutics AG Return On Equity for the quarter ending September 30, 2025 was -26.4 %, a 118% decline year-over-year.
  • CRISPR Therapeutics AG annual Return On Equity for 2024 was -18.5 %, a 119% decline from 2023.
  • CRISPR Therapeutics AG annual Return On Equity for 2023 was -8.44 %, a 73.5% increase from 2022.
  • CRISPR Therapeutics AG annual Return On Equity for 2022 was -31.9 %, a 297% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)

CRISPR Therapeutics AG Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -26.4 -14.3 -118% Jul 1, 2025 Sep 30, 2025
Q2 2025 -25.3 -11.4 -82.2% Apr 1, 2025 Jun 30, 2025
Q1 2025 -20.1 -8.52 -73.7% Jan 1, 2025 Mar 31, 2025
Q4 2024 -18.5 -10 -119% Oct 1, 2024 Dec 31, 2024
Q3 2024 -12.2 +7.29 +37.5% Jul 1, 2024 Sep 30, 2024
Q2 2024 -13.9 +8.33 +37.6% Apr 1, 2024 Jun 30, 2024
Q1 2024 -11.6 +15.4 +57.1% Jan 1, 2024 Mar 31, 2024
Q4 2023 -8.44 +23.4 +73.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 -19.4 +11.9 +38% Jul 1, 2023 Sep 30, 2023
Q2 2023 -22.2 +5.22 +19.1% Apr 1, 2023 Jun 30, 2023
Q1 2023 -27 -39.7 -311% Jan 1, 2023 Mar 31, 2023
Q4 2022 -31.9 -48.1 -297% Oct 1, 2022 Dec 31, 2022
Q3 2022 -31.3 -50.5 -263% Jul 1, 2022 Sep 30, 2022
Q2 2022 -27.4 -51.5 -214% Apr 1, 2022 Jun 30, 2022
Q1 2022 12.8 +40.2 Jan 1, 2022 Mar 31, 2022
Q4 2021 16.2 +45.3 Oct 1, 2021 Dec 31, 2021
Q3 2021 19.2 +39.9 Jul 1, 2021 Sep 30, 2021
Q2 2021 24.1 +21.7 +923% Apr 1, 2021 Jun 30, 2021
Q1 2021 -27.4 -34 -519% Jan 1, 2021 Mar 31, 2021
Q4 2020 -29.1 -40.8 -347% Oct 1, 2020 Dec 31, 2020
Q3 2020 -20.7 -18.1 -695% Jul 1, 2020 Sep 30, 2020
Q2 2020 2.35 +53.8 Apr 1, 2020 Jun 30, 2020
Q1 2020 6.54 +57.4 Jan 1, 2020 Mar 31, 2020
Q4 2019 11.7 +60.1 Oct 1, 2019 Dec 31, 2019
Q3 2019 -2.6 +37.8 +93.5% Jul 1, 2019 Sep 30, 2019
Q2 2019 -51.5 -11.9 -30.1% Apr 1, 2019 Jun 30, 2019
Q1 2019 -50.9 -15.7 -44.7% Jan 1, 2019 Mar 31, 2019
Q4 2018 -48.4 -13.3 -37.9% Oct 1, 2018 Dec 31, 2018
Q3 2018 -40.4 -15.5 -62.1% Jul 1, 2018 Sep 30, 2018
Q2 2018 -39.6 -11.2 -39.5% Apr 1, 2018 Jun 30, 2018
Q1 2018 -35.2 Jan 1, 2018 Mar 31, 2018
Q4 2017 -35.1 Oct 1, 2017 Dec 31, 2017
Q3 2017 -24.9 Jul 1, 2017 Sep 30, 2017
Q2 2017 -28.4 Apr 1, 2017 Jun 30, 2017

CRISPR Therapeutics AG Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -18.5 -10 -119% Jan 1, 2024 Dec 31, 2024
2023 -8.44 +23.4 +73.5% Jan 1, 2023 Dec 31, 2023
2022 -31.9 -48.1 -297% Jan 1, 2022 Dec 31, 2022
2021 16.2 +45.3 Jan 1, 2021 Dec 31, 2021
2020 -29.1 -40.8 -347% Jan 1, 2020 Dec 31, 2020
2019 11.7 +60.1 Jan 1, 2019 Dec 31, 2019
2018 -48.4 -13.3 -37.9% Jan 1, 2018 Dec 31, 2018
2017 -35.1 Jan 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.